Gene · 406943
Papers2,393
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,393
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The microRNA miR-152 can mitigate and prevent the toxic effect of benzene on porcine ovarian cells. | Toxicol In Vitro | 2024 | 38815736 | PubTator, text mining | PubMed |
| Exploration of the Shared Gene Signatures and Molecular Mechanisms Between Ischemic Stroke and Atherosclerosis. | Int J Gen Med | 2024 | 38784404 | PubTator, text mining | PubMed |
| Serum LINC00339 is a promising biomarker for prognosis prediction of nasopharyngeal carcinoma. | Int J Biol Markers | 2024 | 38711286 | PubTator, text mining | PubMed |
| Differential Expression of MicroRNA MiR-145 and MiR-155 Downstream Targets in Oral Cancers Exhibiting Limited Chemotherapy Resistance. | Int J Mol Sci | 2024 | 38396844 | PubTator, text mining | PubMed |
| Breaking paradigms: Long non-coding RNAs forming gene fusions with potential implications in cancer. | Genes Dis | 2024 | 38292185 | PubTator, text mining | PubMed |
| Circular RNA-mediated miRNA sponge & RNA binding protein in biological modulation of breast cancer. | Noncoding RNA Res | 2024 | 38282696 | PubTator, text mining | PubMed |
| LncRNA HOTAIR regulates autophagy and proliferation mechanisms in premature ovarian insufficiency through the miR-148b-3p/ATG14 axis. | Cell Death Discov | 2024 | 38267415 | PubTator, text mining | PubMed |
| Mechanisms of immune checkpoint inhibitors: insights into the regulation of circular RNAS involved in cancer hallmarks. | Cell Death Dis | 2024 | 38177102 | PubTator, text mining | PubMed |
| Correction to: Steroid receptor coactivator-1 enhances the stemness of glioblastoma by activating long noncoding RNA XIST/miR-152/KLF4 pathway. | Cancer Sci | 2024 | 38087965 | PubTator, text mining | PubMed |
| MicroRNA-152 specifically targets kinesin family member 14 to suppress the advancement of bladder cancer cells via PI3K/AKT pathway. | Biochem Biophys Res Commun | 2024 | 38070277 | PubTator, text mining | PubMed |
| Placenta-derived exosomes as carriers of non-coding RNAs in maternal circulation of patients with preeclampsia. | Biotechnol Genet Eng Rev | 2024 | 37130192 | PubTator, text mining | PubMed |
| Extracellular Vesicles in Atherosclerosis: State of the Art. | Int J Mol Sci | 2023 | 38203558 | PubTator, text mining | PubMed |
| The role of ncRNA regulatory mechanisms in diseases-case on gestational diabetes. | Brief Bioinform | 2023 | 38189542 | PubTator, text mining | PubMed |
| Recent progress in the role of endogenous metal ions in doxorubicin-induced cardiotoxicity. | Front Pharmacol | 2023 | 38143497 | PubTator, text mining | PubMed |
| miRNA Expression Profiling in Human Breast Cancer Diagnostics and Therapy. | Curr Issues Mol Biol | 2023 | 38132441 | PubTator, text mining | PubMed |
| Identification and characterization of the anti-viral interferon lambda 3 as direct target of the Epstein-Barr virus microRNA-BART7-3p. | Oncoimmunology | 2023 | 38126030 | PubTator, text mining | PubMed |
| Association between IL-6 and prognosis of gastric cancer: a retrospective study. | Ther Adv Gastroenterol | 2023 | 38026103 | PubTator, text mining | PubMed |
| Downregulated M6A modification and expression of circRNA_103239 promoted the progression of glioma by regulating the miR-182-5p/MTSS1 signalling pathway. | J Cancer | 2023 | 38021156 | PubTator, text mining | PubMed |
| Long non-coding RNA PVT1 (PVT1) affects the expression of CCND1 and promotes doxorubicin resistance in osteosarcoma cells. | J Bone Oncol | 2023 | 38021073 | PubTator, text mining | PubMed |
| The Connection between MiR-122 and Lymphocytes in Patients Receiving Treatment for Chronic Hepatitis B Virus Infection. | Microorganisms | 2023 | 38004743 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406943/papers?page=3